These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
496 related articles for article (PubMed ID: 28631086)
1. Nearly a Third of High-Grade Dysplasia and Colorectal Cancer Is Undetected in Patients with Inflammatory Bowel Disease. Eluri S; Parian AM; Limketkai BN; Ha CY; Brant SR; Dudley-Brown S; Efron JE; Fang SG; Gearhart SL; Marohn MR; Meltzer SJ; Bashar S; Truta B; Montgomery EA; Lazarev MG Dig Dis Sci; 2017 Dec; 62(12):3586-3593. PubMed ID: 28631086 [TBL] [Abstract][Full Text] [Related]
2. Management of low and high-grade dysplasia in inflammatory bowel disease: the gastroenterologists' perspective and current practice in the United Kingdom. Thomas T; Nair P; Dronfield MW; Mayberry JF Eur J Gastroenterol Hepatol; 2005 Dec; 17(12):1317-24. PubMed ID: 16292084 [TBL] [Abstract][Full Text] [Related]
3. High Adherence to Surveillance Guidelines in Inflammatory Bowel Disease Patients Results in Low Colorectal Cancer and Dysplasia Rates, While Rates of Dysplasia are Low Before the Suggested Onset of Surveillance. Singh K; Al Khoury A; Kurti Z; Gonczi L; Reinglas J; Verdon C; Kohen R; Bessissow T; Afif W; Wild G; Seidman E; Bitton A; Lakatos PL J Crohns Colitis; 2019 Sep; 13(10):1343-1350. PubMed ID: 30918959 [TBL] [Abstract][Full Text] [Related]
4. Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis. Venkatesh PG; Jegadeesan R; Gutierrez NG; Sanaka MR; Navaneethan U J Crohns Colitis; 2013 Dec; 7(12):968-73. PubMed ID: 23433613 [TBL] [Abstract][Full Text] [Related]
5. Progression of low-grade dysplasia to advanced neoplasia based on the location and morphology of dysplasia in ulcerative colitis patients with extensive colitis under colonoscopic surveillance. Navaneethan U; Jegadeesan R; Gutierrez NG; Venkatesh PG; Hammel JP; Shen B; Kiran RP J Crohns Colitis; 2013 Dec; 7(12):e684-91. PubMed ID: 23916526 [TBL] [Abstract][Full Text] [Related]
6. Inflammatory bowel disease as a risk factor for colorectal cancer. Lukas M Dig Dis; 2010; 28(4-5):619-624. PubMed ID: 21088413 [TBL] [Abstract][Full Text] [Related]
7. Statin Exposure Is Not Associated with Reduced Prevalence of Colorectal Neoplasia in Patients with Inflammatory Bowel Disease. Shah SC; Glass J; Giustino G; Hove JRT; Castaneda D; Torres J; Kumar A; Elman J; Ullman TA; Itzkowitz SH Gut Liver; 2019 Jan; 13(1):54-61. PubMed ID: 30400722 [TBL] [Abstract][Full Text] [Related]
8. Clinical implications of low grade dysplasia found during inflammatory bowel disease surveillance: a retrospective study comparing chromoendoscopy and white-light endoscopy. Ten Hove JR; Mooiweer E; van der Meulen de Jong AE; Dekker E; Ponsioen CY; Siersema PD; Oldenburg B Endoscopy; 2017 Feb; 49(2):161-168. PubMed ID: 27951611 [No Abstract] [Full Text] [Related]
9. Outcome after surveillance of low-grade and indefinite dysplasia in patients with ulcerative colitis. Pekow JR; Hetzel JT; Rothe JA; Hanauer SB; Turner JR; Hart J; Noffsinger A; Huo D; Rubin DT Inflamm Bowel Dis; 2010 Aug; 16(8):1352-6. PubMed ID: 20027656 [TBL] [Abstract][Full Text] [Related]
10. Colorectal Strictures in Patients With Inflammatory Bowel Disease Do Not Independently Predict Colorectal Neoplasia. Axelrad JE; Faye A; Slaughter JC; Harpaz N; Itzkowitz SH; Shah SC Inflamm Bowel Dis; 2022 Jun; 28(6):855-861. PubMed ID: 34319381 [TBL] [Abstract][Full Text] [Related]
11. High Risk of Advanced Colorectal Neoplasia in Patients With Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease. Shah SC; Ten Hove JR; Castaneda D; Palmela C; Mooiweer E; Colombel JF; Harpaz N; Ullman TA; van Bodegraven AA; Jansen JM; Mahmmod N; van der Meulen-de Jong AE; Ponsioen CY; van der Woude CJ; Oldenburg B; Itzkowitz SH; Torres J Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1106-1113.e3. PubMed ID: 29378311 [TBL] [Abstract][Full Text] [Related]
12. Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010. Herrinton LJ; Liu L; Levin TR; Allison JE; Lewis JD; Velayos F Gastroenterology; 2012 Aug; 143(2):382-9. PubMed ID: 22609382 [TBL] [Abstract][Full Text] [Related]
13. Risk for colorectal neoplasia in patients with inflammatory bowel disease and mucosa indefinite for dysplasia. Lai KK; Horvath B; Xie H; Wu X; Lewis BL; Pai RK; Plesec T; Patil DT; Gordon IO; Wang Y; Shen B; Goldblum JR; Liu X Inflamm Bowel Dis; 2015 Feb; 21(2):378-84. PubMed ID: 25569733 [TBL] [Abstract][Full Text] [Related]
14. Interval Colorectal Cancer in Inflammatory Bowel Disease: The Role of Guideline Adherence. Burke KE; Nayor J; Campbell EJ; Ananthakrishnan AN; Khalili H; Richter JM Dig Dis Sci; 2020 Jan; 65(1):111-118. PubMed ID: 31367882 [TBL] [Abstract][Full Text] [Related]
15. Analysis of DNA Methylation at Specific Loci in Stool Samples Detects Colorectal Cancer and High-Grade Dysplasia in Patients With Inflammatory Bowel Disease. Kisiel JB; Klepp P; Allawi HT; Taylor WR; Giakoumopoulos M; Sander T; Yab TC; Moum BA; Lidgard GP; Brackmann S; Mahoney DW; Roseth A; Ahlquist DA Clin Gastroenterol Hepatol; 2019 Apr; 17(5):914-921.e5. PubMed ID: 29775793 [TBL] [Abstract][Full Text] [Related]